Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances

Abstract

Scar inhibition plays a crucial role in wound healing, particularly in the prevention of excessive scar formation during skin repair. While scar formation is a natural part of the healing process, improper scarring can lead to functional impairment, cosmetic defects, and psychological impacts. Therefore, understanding the mechanisms behind scar inhibition and exploring therapeutic strategies is essential for improving clinical outcomes. This review summarizes the primary mechanisms of scar formation and inhibition, including the regulation of collagen deposition, modulation of the inflammatory response, and control of cell proliferation and migration. In recent years, novel therapeutic approaches have emerged for scar inhibition, including gene therapy, stem cell treatments, and localized drug delivery systems, and the use of biomaterials. These methods not only enhance the effectiveness of scar treatment but also improve the biocompatibility and durability of the healing process. Although some of these approaches have shown promising results in early-stage studies, challenges remain for clinical applications, such as the individualization of treatment plans and the sustainability of outcomes. Finally, this review discusses future research directions and proposes strategies to enhance the potential of scar inhibition therapies and their clinical translation.

Keywords

biomaterials / immune modulation / scar inhibition / signaling pathways / wound healing

References

[1] X. Lin and Y. Lai, “Scarring Skin: Mechanisms and Therapies,” International Journal of Molecular Sciences 25 (2024): 1458.

[2] C. D. Marshall, M. S. Hu, T. Leavitt, L. A. Barnes, H. P. Lorenz, and M. T. Longaker, “Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions,” Advanced Wound Care (New Rochelle) 7 (2018): 29–45.

[3] Z.-C. Wang, W.-Y. Zhao, Y. Cao, et al., “The Roles of Inflammation in Keloid and Hypertrophic Scars,” Frontiers in immunology 11 (2020): 603187.

[4] C. E. Dorrier, D. Aran, E. A. Haenelt, et al., “CNS Fibroblasts Form a Fibrotic Scar in Response to Immune Cell Infiltration,” Nature Neuroscience 24 (2021): 234–244.

[5] C. Han, T. R. Leonardo, B. Romana-Souza, et al., “Microfibril-Associated Protein 5 and the Regulation of Skin Scar Formation,” Scientific Reports 13 (2023): 8728.

[6] Q. Jiang, J. Chen, F. Tian, and Z. Liu, “Silicone Gel Sheeting for Treating Hypertrophic Scars,” Cochrane Database of Systematic Reviews (Online) 9 (2021): CD013357.

[7] M. Sheng, Y. Chen, H. Li, Y. Zhang, and Z. Zhang, “The Application of Corticosteroids for Pathological Scar Prevention and Treatment: Current Review and Update,” Burns Trauma 11 (2023): tkad009.

[8] M. Rahimnejad, S. Derakhshanfar, and W. Zhong, “Biomaterials and Tissue Engineering for Scar Management in Wound Care,” Burns Trauma 5 (2017): 4.

[9] C. Bojanic, K. To, A. Hatoum, et al., “Mesenchymal Stem Cell Therapy in Hypertrophic and Keloid Scars,” Cell and Tissue Research 383 (2021): 915–930.

[10] T. Zhang, X. F. Wang, Z. C. Wang, et al., “Current Potential Therapeutic Strategies Targeting the TGF-β/Smad Signaling Pathway to Attenuate Keloid and Hypertrophic Scar Formation,” Biomedicine & Pharmacotherapy 129 (2020): 110287.

[11] A. W. Segal, “How Neutrophils Kill Microbes,” Annual Review of Immunology 23 (2005): 197–223.

[12] B. M. Delavary, W. M. van der Veer, M. van Egmond, F. B. Niessen, and R. H. Beelen, “Macrophages in Skin Injury and Repair,” Immunobiology 216 (2011): 753–762.

[13] F. O. Martinez and S. Gordon, “The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment,” F1000Prime Rep 6 (2014): 13.

[14] S. Guo and L. A. Dipietro, “Factors Affecting Wound Healing,” Journal of Dental Research 89 (2010): 219–229.

[15] G. Gabbiani, “The Myofibroblast in Wound Healing and Fibrocontractive Diseases,” Journal of Pathology 200 (2003): 500–503.

[16] E. Huet, B. Vallee, D. Szul, et al., “Extracellular Matrix Metalloproteinase Inducer/CD147 Promotes Myofibroblast Differentiation by Inducing α-Smooth Muscle Actin Expression and Collagen Gel Contraction: Implications in Tissue Remodeling,” Faseb Journal 22 (2008): 1144–1154.

[17] G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound Repair and Regeneration,” Nature 453 (2008): 314–321.

[18] E. A. O'Toole, “Extracellular Matrix and Keratinocyte Migration,” ExpDermatol 26, no. 6 (2001): 525–530.

[19] G. G. Gauglitz, H. C. Korting, T. Pavicic, T. Ruzicka, and M. G. Jeschke, “Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies,” Molecular Medicine 17 (2011): 113–125.

[20] E. Shirakami, S. Yamakawa, and K. Hayashida, “Strategies to Prevent Hypertrophic Scar Formation: A Review of Therapeutic Interventions Based on Molecular Evidence,” Burns Trauma 8 (2020): tkz003.

[21] R. Ogawa, “Surgery for Scar Revision and Reduction: From Primary Closure to Flap Surgery,” Burns Trauma 7 (2019): 1–12.

[22] A. A. Tandara and T. A. Mustoe, “The Role of the Epidermis in the Control of Scarring: Evidence for Mechanism of Action for Silicone Gel,” Journal of Plastic, Reconstructive & Aesthetic Surgery 61 (2008): 1219–1225.

[23] S. A. Eming, T. A. Wynn, and P. Martin, “Inflammation and Metabolism in Tissue Repair and Regeneration,” Science 356 (2017): 1026–1030.

[24] B. W. A. Kaitlyn SadtlerKenneth Estrellas and M. T. Wolf, “Developing a Pro-Regenerative Biomaterial Scaffold Microenvironment Requires T Helper 2 Cells,” Science 352 (2016): 366.

[25] Y. Yang, C. Chu, L. Liu, et al., “Tracing immune cells Around biomaterials With spatial anchors During large-scale wound regeneration,” Nature Communications 14 (2023): 5995.

[26] L. A. Kalekar, J. N. Cohen, N. Prevel, et al., “Regulatory T Cells in Skin are Uniquely Poised to Suppress Profibrotic Immune Responses,” Science Immunology 4 (2019): eaaw2910.

[27] N. Ali, B. Zirak, R. S. Rodriguez, et al., “Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation,” Cell 169 (2017): 1119–1129.e11.

[28] D. R. Griffin, M. M. Archang, C. H. Kuan, et al., “Activating an Adaptive Immune Response From a Hydrogel Scaffold Imparts Regenerative Wound Healing,” Nature Materials 20 (2021): 560–569.

[29] S. Zhou, Q. Wang, W. Yang, et al., “Development of a Bioactive Silk Fibroin Bilayer Scaffold for Wound Healing and Scar Inhibition,” International Journal of Biological Macromolecules 255 (2024): 128350.

[30] G. F. A. Chiarini, D. Liu, U. Armato, and I. Dal Pr'a, “Biocompatible Silk Noil-Based Three-Dimensional Carded-Needled Nonwoven Scaffolds Guide the Engineering of Novel Skin Connective Tissue,” Tissue Engineering Part A 22 (2016): 1047–1060.

[31] X. Liu, G. Dou, Z. Li, et al., “Hybrid Biomaterial Initiates Refractory Wound Healing via Inducing Transiently Heightened Inflammatory Responses,” Advanced Science (Weinheim) 9 (2022): e2105650.

[32] M. Horckmans, L. Ring, J. Duchene, et al., “Neutrophils Orchestrate Post-Myocardial Infarction Healing by Polarizing Macrophages Towards a Reparative Phenotype,” European Heart Journal 38 (2017): 187.

[33] T. A. Wynn and K. M. Vannella, “Macrophages in Tissue Repair, Regeneration, and Fibrosis,” Immunity 44 (2016): 450–462.

[34] Y. Rinkevich, G. G. Walmsley, M. S. Hu, et al., “Identification and Isolation of a Dermal Lineage With Intrinsic Fibrogenic Potential,” Science 348 (2015): aaa2151.

[35] D. C.-G. Jiang, S. Christ, A. Stefanska, et al., “Two Succeeding Fibroblastic Lineages Drive Dermal Development and the Transition From Regeneration to Scarring,” Nature Cell Biology 20 (2018): 422–431.

[36] S. Mascharak, H. E. desJardins-Park, M. F. Davitt, et al., “Preventing Engrailed-1 Activation in Fibroblasts Yields Wound Regeneration Without Scarring,” Science 372 (2021): eaba2374.

[37] M. Aragona, T. Panciera, A. Manfrin, et al., “A Mechanical Checkpoint Controls Multicellular Growth Through YAP/TAZ Regulation by Actin-Processing Factors,” Cell 154 (2013): 1047–1059.

[38] S. Dupont, L. Morsut, M. Aragona, et al., “Role of YAP/TAZ in Mechanotransduction,” Nature 474 (2011): 179–183.

[39] S. Mascharak, H. E. Talbott, M. Januszyk, et al., “Multi-Omic Analysis Reveals Divergent Molecular Events in Scarring and Regenerative Wound Healing,” Cell Stem Cell 29 (2022): 315–327.e6.

[40] M. B. Fernando and K. J. Brennand, “Quickly Moving Too Slowly: Interneuron Migration in Timothy Syndrome,” Cell Stem Cell 29 (2022): 181–183.

[41] Q. Zhang, L. Shi, H. He, et al., “Down-Regulating Scar Formation by Microneedles Directly via a Mechanical Communication Pathway,” ACS Nano 16 (2022): 10163–10178.

[42] M. K. Lichtman, M. Otero-Vinas, and V. Falanga, “Transforming Growth Factor Beta (TGF-β) Isoforms in Wound Healing and Fibrosis,” Wound Repair and Regeneration 24 (2016): 215–222.

[43] J. Zhang, Y. Zheng, J. Lee, et al., “A Pulsatile Release Platform Based on Photo-Induced Imine-Crosslinking Hydrogel Promotes Scarless Wound Healing,” Nature Communications 12 (2021): 1670.

[44] L. Lu, A. S. Saulis, W. R. Liu, et al., “The Temporal Effects of Anti-TGF-β1, 2, and 3 Monoclonal Antibody on Wound Healing and Hypertrophic Scar Formation,” Journal of the American College of Surgeons 201 (2005): 391–397.

[45] H. Shiraha, K. Gupta, K. Drabik, and A. Wells, “Aging Fibroblasts Present Reduced Epidermal Growth Factor (EGF) Responsiveness Due to Preferential Loss of EGF Receptors,” Journal of Biological Chemistry 275 (2000): 19343–19351.

[46] R. A. Evans, Y. C. Tian, R. Steadman, and A. O. Phillips, “TGF-β1-Mediated Fibroblast–Myofibroblast Terminal Differentiation—The Role of Smad Proteins,” Experimental Cell Research 282 (2003): 90–100.

[47] B. A. Shook, R. R. Wasko, G. C. Rivera-Gonzalez, et al., “Myofibroblast Proliferation and Heterogeneity Are Supported by Macrophages During Skin Repair,” Science (New York, NY) 362 (2018): eaar2971.

[48] B. A. Shook, R. R. Wasko, O. Mano, et al., “Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair,” Cell Stem Cell 26 (2020): 880–895.e6.

[49] L. Sun, X. Zhang, S. Wu, et al., “Dynamic Interplay Between IL-1 and WNT Pathways in Regulating Dermal Adipocyte Lineage Cells During Skin Development and Wound Regeneration,” Cell Reports 42 (2023): 112647.

[50] C. R. Kruse, K. Nuutila, C. C. Y. Lee, et al., “The External Microenvironment of Healing Skin Wounds,” Wound Repair and Regeneration 23 (2015): 456–464.

[51] Y. Yang, B. Li, M. Wang, S. Pan, Y. Wang, and J. Gu, “Effect of Natural Polymer Materials on Skin Healing Based on Internal Wound Microenvironment: A Review,” Frontiers in Chemistry 11 (2023): 1257915.

[52] M. Xue and C. J. Jackson, “Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring,” Advances in Wound Care (New Rochelle) 4 (2015): 119–136.

[53] L. Wang, L. Hu, X. Zhou, et al., “Exosomes Secreted by Human Adipose Mesenchymal Stem Cells Promote Scarless Cutaneous Repair by Regulating Extracellular Matrix Remodelling,” Scientific Reports 7 (2017): 13321.

[54] Y. An, S. Lin, X. Tan, et al., “Exosomes From Adipose-Derived Stem Cells and Application to Skin Wound Healing,” Cell Proliferation 54 (2021): e12993.

[55] H. M. Nguyen, T. T. Ngoc Le, A. T. Nguyen, H. N. Thien Le, and T. T. Pham, “Biomedical Materials for Wound Dressing: Recent Advances and Applications,” RSC Advances 13 (2023): 5509–5528.

[56] C. Geng, S. He, S. Yu, et al., “Achieving Clearance of Drug-Resistant Bacterial Infection and Rapid Cutaneous Wound Regeneration Using an ROS-Balancing-Engineered Heterojunction,” Advanced Materials 36 (2024): e2310599.

[57] B. Zuhaili, P. Aflaki, T. Koyama, et al., “Meshed Skin Grafts Placed Upside Down Can Take if Desiccation Is Prevented,” Plastic and Reconstructive Surgery 125 (2010): 855–865.

[58] X. Han, L. S. Ju, and J. Irudayaraj, “Oxygenated Wound Dressings for Hypoxia Mitigation and Enhanced Wound Healing,” Molecular Pharmaceutics 20 (2023): 3338–3355.

[59] X. Han, L. Ju, C. Saengow, et al., “Nano Oxygen Chamber by Cascade Reaction for Hypoxia Mitigation and Reactive Oxygen Species Scavenging in Wound Healing,” Bioactive Materials 35 (2024): 67.

[60] L. A. Wallace, L. Gwynne, and T. Jenkins, “Challenges and Opportunities of pH in Chronic Wounds,” Therapeutic Delivery 10 (2019): 719–735.

[61] T. Cui, J. Yu, C.-F. Wang, et al., Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 9 (2022): e2201254.

[62] F. Zhang, H. Zhang, S. Wang, et al., “A Dynamically Phase-Adaptive Regulating Hydrogel Promotes Ultrafast Anti-Fibrotic Wound Healing,” Nature Communications 16 (2025): 3738.

[63] M. V. Plikus, C. F. Guerrero-Juarez, M. Ito, et al., “Regeneration of Fat Cells From Myofibroblasts During Wound Healing,” Science (New York, NY) 355 (2017): 748–752.

[64] T. Weng, P. Wu, W. Zhang, et al., “Regeneration of Skin Appendages and Nerves: Current Status and Further Challenges,” Journal of Translational Medicine 18 (2020): 53.

[65] E. Fuchs, “Scratching the Surface of Skin Development,” Nature 445 (2007): 834–842.

[66] K. Lay, T. Kume, and E. Fuchs, “FOXC1 Maintains the Hair Follicle Stem Cell Niche and Governs Stem Cell Quiescence to Preserve Long-Term Tissue-Regenerating Potential,” PNAS 113 (2016): e1506.

[67] M. Ito, Z. Yang, T. Andl, et al., “Wnt-Dependent De Novo Hair Follicle Regeneration in Adult Mouse Skin After Wounding,” Nature 447 (2007): 316–320.

[68] R. C. Adam, H. Yang, S. Rockowitz, et al., “Pioneer Factors Govern Super-Enhancer Dynamics in Stem Cell Plasticity and Lineage Choice,” Nature 521 (2015): 366–370.

[69] X. Wang, X. Wang, J. Liu, et al., “Hair Follicle and Sebaceous Gland De Novo Regeneration With Cultured Epidermal Stem Cells and Skin-Derived Precursors,” Stem Cells Translational Medicine 5 (2016): 1695–1706.

[70] Y. Chen, Z. Fan, X. Wang, et al., “PI3K/Akt Signaling Pathway is Essential for De Novo Hair Follicle Regeneration,” Stem Cell Research and Therapy 11 (2020): 144.

[71] Z. Liu, X. Hu, Y. Liang, et al., “Glucocorticoid Signaling and Regulatory T Cells Cooperate to Maintain the Hair-Follicle Stem-Cell Niche,” Nature Immunology 23 (2022): 1086–1097.

[72] X. Yin, L. Wang, Y. Niu, et al., “Unmasking Chemokine-Inducing Specificity in Oligosaccharide Biomaterial to Promote Hair Growth,” Advanced Materials 36 (2024): e2304655.

[73] T. Arakawa, S. J. Prestrelski, W. C. Kenney, and J. F. Carpenter, “Factors Affecting Short-Term and Long-Term Stabilities of Proteins,” Advanced Drug Delivery Reviews 46 (2001): 307–326.

[74] X. Yuan, X. Duan, Z. Li, et al., “Collagen Triple Helix Repeat Containing-1 Promotes Functional Recovery of Sweat Glands by Inducing Adjacent Microvascular Network Reconstruction In Vivo,” Burns & Trauma 10 (2022): tkac035.

[75] B. Yu, Z.-Y. He, P. You, et al., “Reprogramming Fibroblasts Into Bipotential Hepatic Stem Cells by Defined Factors,” Cell Stem Cell 13 (2013): 328–340.

[76] B. Yao, W. Song, Z. Li, et al., “Irf6 Directs Glandular Lineage Differentiation of Epidermal Progenitors and Promotes Limited Sweat Gland Regeneration in a Mouse Burn Model,” Stem Cell Research and Therapy 9 (2018): 179.

[77] B. Yao, J. Xie, N. Liu, et al., “Direct Reprogramming of Epidermal Cells Toward Sweat Gland-Like Cells by Defined Factors,” Cell Death and Disease 10 (2019): 272.

[78] M. Kurita, T. Araoka, T. Hishida, et al., “In Vivo Reprogramming of Wound-Resident Cells Generates Skin Epithelial Tissue,” Nature 561 (2018): 243–247.

[79] E. Lujan, S. Chanda, H. Ahlenius, T. C. Südhof, and M. Wernig, “Direct Conversion of Mouse Fibroblasts to Self-Renewing, Tripotent Neural Precursor Cells,” PNAS 109 (2012): 2527–2532.

[80] K. Takahashi, K. Tanabe, M. Ohnuki, et al., “Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors,” Cell 131 (2007): 861–872.

[81] F. Xie, X. Tang, Q. Zhang, and C. Deng, “Reprogramming Human Adipose Tissue Stem Cells Using Epidermal Keratinocyte Extracts,” Molecular Medicine Report 11 (2015): 182–188.

[82] W. Wen, X. Cheng, Y. Fu, et al., “High-Level Precise Knocking of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells,” Stem Cell Reports 10 (2018): 1821–1834.

[83] S. J. Meas, K. Nishimura, M. Scheibinger, and A. Dabdoub, “In Vitro Methods to Cultivate Spiral Ganglion Cells, and Purification of Cellular Subtypes for Induced Neuronal Reprogramming,” Frontiers in Neuroscience 12 (2018): 822.

[84] T. Aasen, A. Raya, M. J. Barrero, et al., “Efficient and Rapid Generation of Induced Pluripotent Stem Cells From Human Keratinocytes,” Nature Biotechnology 26 (2008): 1276–1284.

[85] A. Zhao, L. Yang, K. Ma, et al., “Overexpression of Cyclin D1 Induces the Reprogramming of Differentiated Epidermal Cells Into Stem Cell-Like Cells,” Cell Cycle 15 (2016): 644–653.

[86] G. Bilousova, J. Chen, and D. R. Roop, “Differentiation of Mouse Induced Pluripotent Stem Cells Into a Multipotent Keratinocyte Lineage,” Journal of Investigative Dermatology 131 (2011): 857–864.

[87] Y. You, Y. Tian, Z. Yang, et al., “Intradermally Delivered mRNA-Encapsulating Extracellular Vesicles for Collagen-Replacement Therapy,” Nature Biomedical Engineering 7 (2023): 887–900.

[88] J. Guan, G. Wang, J. Wang, et al., “Chemical Reprogramming of Human Somatic Cells to Pluripotent Stem Cells,” Nature 605 (2022): 325–331.

[89] S. Ji, Y. Li, L. Xiang, et al., “Cocktail Cell-Reprogrammed Hydrogel Microspheres Achieving Scarless Hair Follicle Regeneration,” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11 (2024): e2306305.

[90] J. Lee, C. C. Rabbani, H. Gao, et al., “Hair-Bearing Human Skin Generated Entirely From Pluripotent Stem Cells,” Nature 582 (2020): 399–404.

[91] D. Dutta, I. Heo, and H. Clevers, “Disease Modeling in Stem Cell-Derived 3D Organoid Systems,” Trends in Molecular Medicine 23 (2017): 393–410.

[92] R. Yang, Y. Zheng, M. Burrows, et al., “Generation of Folliculogenic Human Epithelial Stem Cells From Induced Pluripotent Stem Cells,” Nature Communications 5 (2014): 3071.

[93] S. Seifi, A. Shamloo, S. N. Tavoosi, A. Almasi-Jaf, H. Shaygani, and M. R. Sayah, “A Novel Multifunctional Chitosan-Gelatin/Carboxymethyl Cellulose-Alginate Bilayer Hydrogel Containing Human Placenta Extract for Accelerating Full-Thickness Wound Healing,” International Journal of Biological Macromolecules 253 (2023): 126929.

[94] H. Zhang, M. Song, C. Hu, et al., “Efficient Scarless Skin Regeneration Enabled by Loading Micronized Amnion in a Bioinspired Adhesive Wound Dressing,” Aggregate 4, no. 5 (2023): 4.

[95] J.-L. Yin, Y. Wu, Z.-W. Yuan, X.-H. Gao, and H.-D. Chen, “Advances in Scarless Foetal Wound Healing and Prospects for Scar Reduction in Adults,” Cell Proliferation 53 (2020): e12916.

[96] X. Zheng, Z. Ding, W. Cheng, et al., “Microskin-Inspired Injectable MSC-Laden Hydrogels for Scarless Wound Healing With Hair Follicles,” Advanced Healthcare Materials 9 (2020): e2000041.

[97] P. Li and X. Guo, “A Review: Therapeutic Potential of Adipose-Derived Stem Cells in Cutaneous Wound Healing and Regeneration,” Stem Cell Research and Therapy 9 (2018): 302.

[98] M. Zhao, M. Kang, J. Wang, et al., “Stem Cell-Derived Nanovesicles Embedded in Dual-Layered Hydrogel for Programmed ROS Regulation and Comprehensive Tissue Regeneration in Burn Wound Healing,” Advanced Materials (Deerfield Beach, Fla) 36 (2024): e2401369.

[99] A. K. Gaharwar, I. Singh, and A. Khademhosseini, “Engineered Biomaterials for In Situ Tissue Regeneration,” Nature Reviews Materials 5 (2020): 686–705.

[100] R. M. Visalakshan, M. N. MacGregor, S. Sasidharan, et al., “Biomaterial Surface Hydrophobicity-Mediated Serum Protein Adsorption and Immune Responses,” ACS Applied Materials Interfaces 11 (2019): 27615–27623.

[101] M. Bartneck, H. A. Keul, S. Singh, et al., “Rapid Uptake of Gold Nanorods by Primary Human Blood Phagocytes and Immunomodulatory Effects of Surface Chemistry,” ACS Nano 4 (2010): 3073–3086.

[102] S. Gallorini, F. Berti, G. Mancuso, et al., “Toll-Like Receptor 2 Dependent Immunogenicity of Glycoconjugate Vaccines Containing Chemically Derived Zwitterionic Polysaccharides,” PNAS 106 (2009): 17481–17486.

[103] Y. Zhang, S. Wang, Y. Yang, et al., “Scarless Wound Healing Programmed by Core-Shell Microneedles,” Nature Communications 14 (2023): 3431.

[104] X. Zhou, Z. Wang, Y. K. Chan, et al., “Engineering of a Hollow-Structured Nanocatalytic Membrane for Rapid Infection Control and Enhanced Wound Healing,” Advanced Functional Materials 32 (2022): 7.

[105] Q. Zeng, X. Qi, G. Shi, M. Zhang, and H. Haick, “Wound Dressing: From Nanomaterials to Diagnostic Dressings and Healing Evaluations,” ACS Nano 16 (2022): 1708–1733.

[106] J. A. Shadish, G. M. Benuska, and C. A. DeForest, “Bioactive Site-Specifically Modified Proteins for 4D Patterning of Gel Biomaterials,” Nature Materials 18 (2019): 1005–1014.

[107] M. A. Nishiguchi, C. A. Spencer, D. H. Leung, and T. H. Leung, “Aging Suppresses Skin-Derived Circulating SDF1 to Promote Full-Thickness Tissue Regeneration,” Cell Reports 24 (2018): 3383–3392.e5.

[108] S. Sinha, H. D. Sparks, E. Labit, et al., “Fibroblast Inflammatory Priming Determines Regenerative Versus Fibrotic Skin Repair in Reindeer,” Cell 185 (2022): 4717–4736.e25.

[109] D. Correa-Gallegos, H. Ye, B. Dasgupta, et al., “CD201+ Fascia Progenitors Choreograph Injury Repair,” Nature 623 (2023): 792–802.

[110] M. T. Tierney, L. Polak, Y. Yang, et al., “Vitamin A Resolves Lineage Plasticity to Orchestrate Stem Cell Lineage Choices,” Science (New York, NY) 383 (2024): eadi7342.

[111] O. A. Peña and P. Martin, “Cellular and Molecular Mechanisms of Skin Wound Healing,” Nature Reviews Molecular Cell Biology 25 (2024): 599.

[112] P. Martin, C. Pardo-Pastor, R. G. Jenkins, and J. Rosenblatt, “Imperfect Wound Healing Sets the Stage for Chronic Diseases,” Science (New York, NY) 386: eadp2974.

[113] Y. Wang, K. Vizely, C. Y. Li, et al., “Biomaterials for Immunomodulation in Wound Healing,” Regenerative Biomaterials 11 (2024): rbae032.

RIGHTS & PERMISSIONS

2026 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.